Riskpilot← Back to searchSign inGet full accessRespirium AB
ABActiveOrg 5590331137Sandlyckans Väg 39Day spa, sauna and steam bath activities · NACE 9623Est. 20150 employees
Revenue 2024
SEK 4K
-7% vs 2023
EBITDA margin
-191.5%
-118% vs 2023
Equity ratio
100.2%
Financial strength
Net profit 2024
SEK -7K
-113% vs 2023
| Revenue | SEK 4K | -7% |
| EBITDA | SEK -7K | -118% |
| Net profit | SEK -7K | -113% |
| Total assets | SEK 88K | +25% |
| Equity | SEK 88K | -7% |
| Employees | 0 | — |
Legal name
Respirium AB
Org number
5590331137
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
2 november 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget kommer arbeta med tjänster inom hälsa och friskvård. Vi kommer erbjuda massageterapi och rådgivning för löpteknik.
Address
Sandlyckans Väg 39
Email
cissi.backman@icloud.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 | 19 | 26 | 4 | 4 |
| Staff expenses | — | — | −2 | −0 | — |
| EBITDA | −7 | 6 | 13 | −3 | −7 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −7 | 6 | 13 | −3 | −7 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | −7 | 6 | 13 | −3 | −7 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −7 | 6 | 13 | −3 | −7 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 79 | 85 | 100 | 70 | 88 |
| Equity | 79 | 85 | 98 | 95 | 88 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 0 | 0 | 2 | −25 | −0 |
| Total debt | — | — | 2 | −25 | −0 |
EBITDA margin
-191.5%
This company
15.8%
Market median
-1312% vs market
20202024
Equity ratio
100.2%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-7.9%
This company
18.4%
Market median
-143% vs market
20202024
Net profit margin
-180.8%
This company
8.1%
Market median
-2332% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
-0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-10-01 – 2020-09-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CH Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Respirium AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Helene Backman | Chief Executive Officer | 0 companies |
| Lars Daniel Backman | Chairman | 0 companies |
| Lena Margareta Ljungberg | Deputy Board Member | 0 companies |